scispace - formally typeset
Open AccessJournal ArticleDOI

Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses.

TLDR
The etiologic and pathogenetic similarities between these birth defects, specifically their unique deficiencies in global processes including ribosome biogenesis, DNA damage repair, and pre‐mRNA splicing, all of which affect neural crest cell development and result in similar tissue‐specific defects are emphasized.
Abstract
Craniofacial anomalies account for approximately one-third of all congenital birth defects reflecting the complexity of head and facial development. Craniofacial development is dependent upon a multipotent, migratory population of neural crest cells, which generate most of the bone and cartilage of the head and face. In this review, we discuss advances in our understanding of the pathogenesis of a specific array of craniofacial anomalies, termed facial dysostoses, which can be subdivided into mandibulofacial dysostosis, which present with craniofacial defects only, and acrofacial dysostosis, which encompasses both craniofacial and limb anomalies. In particular, we focus on Treacher Collins syndrome, Acrofacial Dysostosis-Cincinnati Type as well as Nager and Miller syndromes, and animal models that provide new insights into the molecular and cellular basis of these congenital syndromes. We emphasize the etiologic and pathogenetic similarities between these birth defects, specifically their unique deficiencies in global processes including ribosome biogenesis, DNA damage repair, and pre-mRNA splicing, all of which affect neural crest cell development and result in similar tissue-specific defects. WIREs Dev Biol 2017, 6:e263. doi: 10.1002/wdev.263 For further resources related to this article, please visit the WIREs website.

read more

Content maybe subject to copyright    Report

The University of Manchester Research
Rare syndromes of the head and face: mandibulofacial and
acrofacial dysostoses
DOI:
10.1002/wdev.263
Document Version
Accepted author manuscript
Link to publication record in Manchester Research Explorer
Citation for published version (APA):
Terrazas, K., Dixon, J., Trainor, P. A., & Dixon, M. (2017). Rare syndromes of the head and face: mandibulofacial
and acrofacial dysostoses. Wiley Interdisciplinary Reviews: Developmental Biology , 6(3), [e263].
https://doi.org/10.1002/wdev.263
Published in:
Wiley Interdisciplinary Reviews: Developmental Biology
Citing this paper
Please note that where the full-text provided on Manchester Research Explorer is the Author Accepted Manuscript
or Proof version this may differ from the final Published version. If citing, it is advised that you check and use the
publisher's definitive version.
General rights
Copyright and moral rights for the publications made accessible in the Research Explorer are retained by the
authors and/or other copyright owners and it is a condition of accessing publications that users recognise and
abide by the legal requirements associated with these rights.
Takedown policy
If you believe that this document breaches copyright please refer to the University of Manchester’s Takedown
Procedures [http://man.ac.uk/04Y6Bo] or contact uml.scholarlycommunications@manchester.ac.uk providing
relevant details, so we can investigate your claim.
Download date:10. Aug. 2022

Focus Article
Rare syndromes of the head
and face: mandibulofacial
and acrofacial dysostoses
AQ1 Karla Terrazas,
1
Jill Dixon,
2
Paul A. Trainor
1,3
and Michael J. Dixon
2
*
Craniofacial anomalies account for approximately one-third of all congenital
birth defects reecting the complexity of head and facial development. Craniofa-
cial development is dependent upon a multipotent, migratory population of neu-
ral crest cells, which generate most of the bone and cartilage of the head and
face. In this review, we discuss advances in our understanding of the pathogene-
sis of a specic array of craniofacial anomalies, termed facial dysostoses , which
can be subdivided into mandibulofacial dysostosis, which present with craniofa-
cial defects only, and acrofacial dysostosis, which encompasses both craniofacial
and limb anomalies. In particular, we focus on Treacher Collins syndrome, Acro-
facial Dysostosis-Cincinnati Type as well as Nager and Miller syndromes, and
animal models that provide new insights into the molecular and cellular basis of
these congenital syndromes. We emphasize the etiologic and pathogenic simila-
rities between these birth defects, specically their unique deciencies in global
processes including ribosome biogenesis, DNA damage repair, and pre-mRNA
splicing, all of which affect neural crest cell development and result in similar
tissue-specic defects.
© 2016 Wiley Periodicals, Inc.
How to cite this article:
WIREs Dev Biol 2016, e263. doi: 10.1002/wdev.263
INTRODUCTION
AQ3
T
AQ3 he craniofacial complex houses and protects the
brain and most of the bodys primary sense
organs and is essential for feeding and respiration.
Composed of nerves, muscles, cartilage, bone and
connective tissue, head and facial development begins
during early embryogenesis with formation of the
frontonasal prominence and the pharyngeal arches,
which are transient medial and lateral outgrowths of
cranial tissue (Figure 1). The frontonasal prominence
ultimately gives rise to the forehead and the nose,
while the reiterated pattern of paired pharyngeal
arches give rise to the jaws and parts of the neck.
2
The basic structure of each prominence and arch is
the same. Externally, they are composed of ectoderm,
which with respect to the pharyngeal arches, forms
the pharyngeal clefts or grooves. Internally, the fron-
tonasal prominence and pharyngeal arches are lined
with endoderm, which forms the pharyngeal
pouches. At the junctions that separate the pharyn-
geal arches, the end oderm contacts the ectoderm by
an active movement called out-pocketing.
24
Between
the ectoderm and endoderm epithelia is a mesenchy-
mal core. In the frontonasal prominence the core is
composed of neural crest cells (NCCs), while in the
pharyngeal arches the mesenchymal core is composed
of both NCC and mesoderm.
5,6
NCC are a multipo-
tent progenitor cell population that is derived from
the neuroepithelium, undergoes an epithelial to mes-
enchymal transformation, delaminates and then
migrates, colonizing the frontonasal prominence and
pharyngeal arches
2,3
(Figure 1(a)(c)). Collectively,
these four tissues, ectoderm, endoderm, NCC, and
*Correspondence to: mike.dixon@manchester.ac.uk
1
Stowers Institute for Medical Research, Kansas City, MO, USA
2
Division of Dentistry, Faculty of Biology, Medicine & Health,
Michael Smith Building, University of Manchester, Manches-
ter, UK
3
Department of Anatomy and Cell Biology, University of Kansas
Medical Center, Kansas City, KS, USA
AQ2
Conict of interest: The authors have declared no conicts of inter-
est for this article.
© 2016 Wiley Periodicals, Inc. 1of17
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110

mesoderm, interact to give rise to the skeletal, muscu-
lar, vascular, and nervous tissue elements of the head
and neck
2,7,8
(Figure 1(d)(f )). The complexity of
craniofacial development renders it susceptible to
developmental anomalies. Approximately one third
of all congenital anomalies affect the head and face
and, to date, more than 700 distinct craniofacial syn-
dromes have been described.
The facial dysostoses describe a set of rare, clini-
cally and etiologically heterogeneous anomalies of the
craniofacial skeleton. Facial dysostoses arise as a con-
sequence of abnormal development of the rst and sec-
ond pharyngeal arches and their derivatives, including
the upper and lower jaw and their hyoid support struc-
tures. Facial dysostoses can be subdivided into mandi-
bulofacial dysostosis and acrofacial dysostosis.
Mandibulofacial dysostosis (OMIM610536)
9
mani-
fests at birth as maxillary, zygomatic, and mandibular
hypoplasia (Figure 2), together with cleft palate, and/or
ear defects. Many distinct mandibulofacial dysostosis
syndromes have been described; however, clinically,
the best understood is Treacher Collins syndrome
(TCS; OMIM 154500).
1013
In contrast, acrofacial
dysostoses present with craniofacial anomalies similar
to those observed in mandibulofacial dysostosis but
with the addition of limb defects. The acrofacial dysos-
toses include the well-characterized disorders of Miller
syndrome (OMIM263750)
14,15
and Nager syndrome
(OMIM154400)
1618
as well as more recently identi-
ed conditions such as Acrofacial Dysostosis-
Cincinnati type (OMIM616462).
19
TREACHER COLLINS SYNDROME
TCS occurs with an incidence estimated at 1:50,000
live births.
9,20
TCS is dened clinically by bilaterally
symmetrical features that include hypoplasia (under-
development) of the facial bones, in particular the
mandible (lower jaw) and zygomatic complex (cheek
bones), coloboma (notching) of the lower eyelids;
downward slanting of the palpebral ssures (opening
E8.25LacZ
(a) (b) (c)
(d) (e) (f)
TUJ1
E10.5
Mouse
E18.5
Human
adult
Mandible
Mandible
Maxilla
Maxilla
Frontal bone
Frontal bone
Alizarin red
Alcian blue
E8.5
FNP
PA1
PA2
E9.5
FIGURE 1
|
Neural crest cells and craniofacial development. (ac)
Mef2c-F10N
-Lacz
1
whole-mount expression marking migrating neural crest
cells as they migrate away from the dorsal neural tube to colonize the frontonasal prominence (FNP) and pharyngeal arches 1 and 2 (PA1,PA2).
(df ) NCC derivatives. (d) TUJ1 whole-mount immunostaining for NCC and placode-derived neurons. (e) Alizarin red and alcian blue staining for
bone and cartilage, respectively. Frontal bone derived from the FNP, and maxilla and mandible derived from PA1. (f ) Schematic of the NCC-
derived craniofacial bones of a healthy human adult. Frontal bone derived from the FNP, and maxilla and mandible derived from PA1.
Focus Article wires.wiley.com/devbio
2of17 © 2016 Wiley Periodicals, Inc.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110

between the eyelids); microtia or atresia (under-
development or absence) of the external ears; nar-
rowing of the ear canal, often resulting in conductive
hearing loss (Figure 2); and micrognathia (small
lower jaw) with or without cleft and/or high-arched
palate.
9,20,21
A considerable degree of interfamilial
and, in multigeneration families, intrafamilial varia-
tion has been observed.
11,12
In severely affected
cases, TCS may result in perinatal death due to a
compromised airway.
13
In contrast, individuals may
be so mildly affected that it can be difcult to estab-
lish an unequivocal diagnosis solely by clinical exam-
ination. Indeed, some patients are only diagnosed
after the birth of a more severely affected child.
The Genetic Basis of TCS
A combination of genetic, physical, and transcript
mapping led to the identication of causative muta-
tions for TCS in the gene-designated TCOF1 on
chromosome 5q32 in humans.
10
The major TCOF1
transcript was found to comprise an open-reading
frame of 4233 bp encoded by 26 exons.
22,23
How-
ever, two alternatively spliced exons, exon 6A and
exon 16A, may also be present in the minor
transcripts.
24
Several hundred largely family-specic
deletions, insertions, splicing, and nonsense muta-
tions have subsequently been identied
22,2531
with
partial gene deletions accounting for a small propor-
tion of all mutations.
32,33
The typical effect of the
mutations is the introduction of a premature termina-
tion codon and the induction of nonsense-mediated
mRNA degradation, leading to haploinsufciency of
TCOF1. This hypothesis is supported by the observa-
tion that cells derived from TCS patients exhibit sig-
nicantly reduced levels of TCOF1, with the mutant
allele being less abu ndant than its wild-type counter-
part.
34
To date, only a very small number of mis-
sense mutations have been identied and these all
affect amino acid residues toward the N-terminus of
the protein either within, or close to, a putative
nuclear export signal.
26,29
While usually character-
ized by an autosomal dominant mode of transmis-
sion, approximately 60% of cases do not have a
previous family history and arise presumably as the
result of a de novo mutation.
35
It is important to
note, however, there is at least one reported case of
recessive inheritance in association with TCS.
36
In
this instance, a homozygous nonsense mutation in
TCOF1 was identied in an individual in which the
PA6
Healthy development
(a) (b)
(c) (d)
Zygomatic arch
Maxilla
Mandible
Zygomatic arch
Mandibulofacial
dysostosis
Maxilla
Mandible
PA4 PA3 PA2 PA1
PA6 PA4 PA3 PA2 PA1
FIGURE 2
|
Mandibulofacial dysostosis. (a) Schematic of the pharyngeal arches of a healthy human embryo. (b) Maxilla and mandible bone
structures derived from neural crest cells that colonize the rst pharyngeal arch. (c) Schematic of the pharyngeal arches of a human embryo with
mandibulofacial dysostosis which arises as a consequence of hypoplastic rst and second pharyngeal arches. (d) Hypoplastic maxilla and mandible
bone structures observed in mandibulofacial dysostoses.
WIREs Developmental Biology Mandibulofacial and acrofacial dysostoses
© 2016 Wiley Periodicals, Inc. 3of17
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110

carrier parents were completely normal clinically.
The mutation was likely previously missed by direct
Sanger sequencing, due to the expectation of a heter-
ozygous sequence chromatogram peak given the
characteristic autosomal dominant nature of the
disease.
Collectively, about 80% of TCS cases are
thought to be caused by mutations in TCOF1, which
encodes the nucleolar phosphoprotein, Treacle
(Figure 3). As all the large, multigeneration TCS
families analyzed exhibited linkage to polymorphic
markers within human chromosome 5q32, TCS was
originally considered to be genetically homogeneous.
However, despite extensive searches, the causative
mutation in a subset of patients exhibiting classic fea-
tures of TCS remained unidentied. The use of
genome-wide copy number analysis in a child with
TCS who was negative for a TCOF1 mutation, led
to the identication of a de novo 156-kb deletion
within human chromosome 13q12.2 that resulted in
deletion of the entire POLR1D gene.
37
POLR1D
encodes a subunit of RNA polymerase I and III
(Figure 3).
37
Subsequently, a further 242 individuals
with classic features of TCS, but who were negative
Treacle
(a)
(b)
UBF SL1
rRNA
Ribosome
proteins
Mature
ribosomes
1
3
2
p53
MDM2
Pol I
POLR1D
18S 5.8S 28S
Nucleolus Nucleus Cytoplasm
POLR1C
Pol III
POLR1D
POLR1C
Treacle
UBF SL1
rRNA
Ribosome
proteins
Mature
ribosomes
1
3
2
5S
p53
MDM2
Pol I
POLR1D
18S
5.8S 28S
Nucleolus Nucleus Cytoplasm
POLR1C
Pol III
POLR1D
POLR1C
FIGURE 3
|
Ribosome biogenesis. (a) Wild-type cell. 1, normal ribosome biogenesis; 2, normal MDM2 inhibition of p53; and 3, normal protein
synthesis, cell growth and cell proliferation. (b)
Tcof1
+/
,
polr1c
/
,
polr1d
-/-
cell. 1, nucleolar stress and decreased ribosome biogenesis;
2, ribosomal proteins bound to MDM2 causing a conformational change leading to enhanced p53 expression; and 3, decreased protein synthesis,
cell cycle arrest and apoptosis.
Focus Article wires.wiley.com/devbio
4of17 © 2016 Wiley Periodicals, Inc.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110

Citations
More filters
Journal ArticleDOI

Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. Vol. 279 (2004) 44475–44482

TL;DR: It is proposed that the MDM 2-L5-L11-L23 complex functions to inhibit MDM2-mediated p53 ubiquitination and thus activates p53.
Journal ArticleDOI

Older paternal age and fresh gene mutation: data on additional disorders

TL;DR: Older paternal age has been found to be a factor in acrodysostosis and progeria, suggesting a fresh mutant gene etiology for these two conditions in which virtually all cases have been sporadic and the mode of genetic etiology has been unknown.
Journal ArticleDOI

The pathogenesis of the Treacher Collins syndrome (mandibulofacial dysostosis)

TL;DR: Microscopic study of the induced ear and jaw defects revealed that the animal model was closely comparable in all respects to human mandibulofacial dysostosis, suggesting a mechanism of malformation which operates early in embryogenesis, acting uniformly on parts which are derived from neural crest cells.
Journal ArticleDOI

Treacher Collins syndrome mutations in Saccharomyces cerevisiae destabilize RNA polymerase I and III complex integrity.

TL;DR: The molecular basis of TCS mutations in Saccharomyces cerevisiae is elucidated, and a new model for how T CS mutations may disrupt Pol I and III complex integrity is presented.
Journal ArticleDOI

Developmental processes regulate craniofacial variation in disease and evolution.

TL;DR: This review provides an example of how shared and interacting developmental processes may explain convergence of phenotypes in spliceosomopathies and ribosomopathy, and discusses three major mechanisms that contribute to variation in developmental processes: genetic background, gene–environment interactions, and developmental stochasticity.
References
More filters
Journal ArticleDOI

p53, the Cellular Gatekeeper for Growth and Division

TL;DR: The author regrets the lack of citations for many important observations mentioned in the text, but their omission is made necessary by restrictions in the preparation of review manuscripts.
Journal ArticleDOI

Mdm2 promotes the rapid degradation of p53

TL;DR: It is proposed that the Mdm2-promoted degradation of p53 provides a new mechanism to ensure effective termination of the p53 signal.
MonographDOI

The neural crest

TL;DR: The Neural Crest is a structure unique to the vertebrate embryo, which has only a transient existence in early embryonic life as discussed by the authors, and the ontogeny of the neural crest embodies the most important issues in developmental biology.
Journal ArticleDOI

Exome sequencing identifies the cause of a Mendelian disorder

TL;DR: Exome sequencing of a small number of unrelated affected individuals is a powerful, efficient strategy for identifying the genes underlying rare mendelian disorders and will likely transform the genetic analysis of monogenic traits.
Journal ArticleDOI

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

TL;DR: This Review of in vitro studies, human tumour data and recent mouse models shows that p53 post-translational modifications have modulatory roles, and MDM2 andMDM4 have more profound roles for regulating p53.
Related Papers (5)
Frequently Asked Questions (16)
Q1. What are the contributions in "Rare syndromes of the head and face: mandibulofacial and acrofacial dysostoses" ?

Dixon et al. this paper described a set of rare, clinically and etiologically heterogeneous anomalies of the craniofacial skeleton. 

One possibility is that DHODH loss-of-function disrupts the transcriptional elongation of genes specifically required for NCC, bone and cartilage development. It is crucial that as the authors continue to investigate the developmental and disease roles for these genes and processes using animal models that they explore the possibility for interactions between each of these genes with other genes and pathways important for NCC, bone and cartilage development. 

Differential regulation of gene expression, transcription factors or posttranslational modifications as well as the type and location of the mutation could each contribute to the underlying cause of the tissue-specific phenotypes observed in ribosomopathies and other mandibulofacial and acrofacial dysostoses. 

p53 functions as a tumor suppressor, and inhibiting p53 could potentially lead to tumorigenic side effects emphasizing the need to explore additional avenues for preventing TCS and other ribosomopathies that affect head and facial development. 

γH2AXpositive neuroepithelial cells were labeled with phosphorylated Chk2 (cell cycle checkpoint kinase 2), a protein that transmits the DNA damage response signal to the apoptotic pathway and caspase 3 (a marker of apoptosis). 

46 Importantly, depletion of Treacle drastically alters the localization of UBF and PolI indicating an essential role for Treacle in nucleolar retention of these two proteins, possibly by actingas a scaffold protein to maintain PolI in the nucleolus. 

The elevated expression of ribosomeassociated genes in neuroepithelial cells and progenitor NCC may make them more sensitive to perturbations in ribosome biogenesis. 

Similar to deficient ribosome biogenesis, it is possible that the highly proliferative nature of NCC, as well as bone and cartilage progenitors makes them more susceptible to defects in mRNA splicing. 

55 Treacle’s role in ribosome biogenesis has also been documented using the Y10B antibody, which recognizes epitopes of rRNA56 and is used as a marker of mature ribosomes. 

Miller syndrome (OMIM263750), also termed postacrofacial dysostosis (POADS), Genee-Wiedemann, and Wildervanck-Smith syndromes, is classified as an acrofacial dysostosis disorder. 

19,67 Acrofacial Dysostosis-Cincinnati type was recently defined in three affected individuals with variable phenotypes ranging from mild mandibulofacial dysostosis to more severe acrofacial dysostosis.19 

TUNEL assays subsequently revealed that polr1a is required for neuroepithelial cell survival and the generation of NCC but is not required for the survival of migrating NCC,19 which is similar to the established roles of Tcof1, polr1c and polr1d. 

56 Homotypic transplantation of Di-labeled midbrain and hindbrain tissue demonstrated that Treacle functions cellautonomously to promote neuroepithelial and progenitor NCC proliferation and survival through dynamic regulation of the spatiotemporal productionof mature ribosomes in neuroepithelial cells and NCC.48 Consistent with these observations, a recent study also proposed a link between Treacle and ribosome biogenesis associated factors in NCC development. 

Consistent with this idea, translation blocking morpholino knockdown of Sf3b4 in Xenopus embryos resulted in a decrease in NCC progenitors as a consequence of cell death. 

In this scenario, core ribosome components, could act differently inspecific tissues due to their interaction with transient proteins, cis-regulatory elements or other cofactors that are present within specific subsets of mRNAs.92 Acrofacial dysostoses, such as MFDM and Nager syndrome, can arise through perturbations of global processes other than ribosome biogenesis and yet still exhibit similar defects in cranial NCC and bone and cartilage development. 

To understand these mechanisms, screening for eye anomalies in MFDM patients and for craniofacial anomalies in MAC patients is needed.